BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2007
View Archived Issues
Parathyroid hormone (1-84) reduces vertebral fracture risk in postmenopausal women
Read More
Novel treatment options for urological disorders claimed in recent patents
Read More
Recent patents disclose new therapeutic agents for depression and psychosis
Read More
Novel therapeutic options for inflammatory disorders disclosed in recent patents
Read More
New treatment strategy for HIV infection disclosed in recent GSK patent
Read More
Genentech extends research collaboration with Seattle Genetics
Read More
BioCryst updates Fodosine development program
Read More
ADH-1 plus melphalan studied for treatment of melanoma
Read More
StormBio and Imperial Innovations sign agreement for pandemic flu treatment
Read More
Yale scientist receives funding to study nanoparticle therapy for prostate cancer
Read More
PF-03187207 begins clinical testing for glaucoma
Read More
Oxford BioMedica and sanofi-aventis enter agreement for TroVax
Read More
Acuity, Froptix and eXegenics to merge to form Opko
Read More
SRI and Blanca to jointly develop Blanca's carbacephem antibiotic drug candidates
Read More
MorphoSys and Astellas enter antibody partnership
Read More
Positive findings for MN-166 in relapsing MS
Read More
AS-1552133 shows improved preclinical cholesterol- and triglyceride-lowering activity
Read More
The HER/VEGFR2 inhibitor BMS-690514, a clinical candidate for the treatment of solid tumors
Read More
Kyorin's PAA-3352 shows antidiabetic activity in vivo
Read More
New experimental approaches in glaucoma therapy
Read More
CeNeS files first IND for M6G
Read More
Carrington and IVI collaborate on sublingual vaccine development
Read More
PRX-302 begins phase I study for BPH
Read More
Pieris antitumor activity of VEGF-specific Anticalin in preclinical studies
Read More
High concentrations of AR-709 reached in key lung compartments
Read More
ACE-393 completes phase I trials for travelers' diarrhea
Read More
NDA filing for methylnaltrexone for treatment of opioid-induced constipation
Read More
Orencia recommended for approval in E.U. for rheumatoid arthritis
Read More
Approvable letter for Nuvigil
Read More